Dry Powder Inhaler

DEVICE10 trials

Sponsors

AZTherapies, Inc., Wake Forest University Health Sciences, Pulmovant, Inc., Rein Therapeutics, AstraZeneca

Conditions

AsthmaAsthma (Diagnosis)COPDCOPD ExacerbationCardiovascular DiseasesFibrosisHealthy VolunteerHealthy Volunteers

Phase 1

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

CompletedNCT02482324

AZTherapies, Inc.Healthy Volunteers

Start: 2015-06-30End: 2015-07-31Updated: 2015-07-21

A Study of Inhaled AZD8630 in Adolescents With Asthma

CompletedNCT07065331

AstraZenecaAsthma

Start: 2025-06-11End: 2025-09-19Updated: 2025-10-14

A Phase 1 Study of Mosliciguat in Healthy, Adult Males

CompletedNCT07185321

Pulmovant, Inc.Healthy Volunteer

Start: 2025-06-10End: 2025-07-13Updated: 2026-06-16

Phase 2

A Study of Mosliciguat in PH-ILD

Active, not recruitingNCT06635850

Pulmovant, Inc.Cardiovascular Diseases, Fibrosis, Interstitial Lung Disease +3

Start: 2024-10-29End: 2028-01-01Updated: 2026-09-10

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

RecruitingNCT06968845

Rein TherapeuticsIdiopathic Pulmonary Fibrosis (IPF)

Start: 2026-02-02End: 2027-12-31Target: 120Updated: 2026-09-04

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

RecruitingNCT07333183

Pulmovant, Inc.Cardiovascular Diseases, Fibrosis, Interstitial Lung Disease (ILD) +3

Start: 2025-12-23End: 2028-01-01Target: 20Updated: 2026-09-02

Phase 3

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

RecruitingNCT07816185

Pulmovant, Inc.Cardiovascular Diseases, Fibrosis, Interstitial Lung Disease +2

Start: 2026-08-31End: 2029-08-31Target: 376Updated: 2026-09-11

Phase 4

Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

TerminatedNCT03219866

Wake Forest University Health SciencesCOPD, COPD Exacerbation

Start: 2017-10-03End: 2020-04-01Updated: 2021-06-22

Unknown Phase

An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981)

Active, not recruitingNL-OMON46129

GlaxoSmithKlinechronic obstructive airways disease (COPD)

Start: 2017-06-29Target: 360Updated: 2024-02-28

Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler

Not yet recruitingNCT07372573

University of Health Sciences LahoreAsthma (Diagnosis)

Start: 2026-02-01End: 2026-07-31Target: 210Updated: 2026-01-28